Trial · NCT07912099
Multimodal Manual Therapy vs. Maitland Mobilization for Chronic Non-Specific Neck Pain
NCT07912099, Not applicable, Active not recruiting, University of Management and Technology Lahore
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Multimodal Manual Therapy vs. Maitland Mobilization for Chronic Non-Specific Neck Pain. Trials, record NCT07912099. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912099
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Multimodal Manual Therapy vs. Maitland Mobilization for Chronic Non-Specific Neck Pain
- NCT number
- NCT07912099
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 64 participants, actual
- Lead sponsor
- University of Management and Technology Lahore
- Conditions
- Chronic Neck Pain
- Interventions
- Maitland Mobilization Treatment Approach, Manual therapy protocol
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | PAIN BY NUMERIC PAIN RATING SCALE | At baseline and after 6 weeks | Pain intensity was measured using the NPRS, an 11-point scale ranging from 0 (\\no pain") to 10 (\\worst imaginable pain"). NPRS is widely validated and used for assessing pain severity in clinical populations. The Minimal Clinically Important Change (MCIC) for the NPRS in individuals with chronic musculoskeletal pain is 2.0 points or a 33.0% change score |
| Primary | Disability by NECK DISABILITY INDEX (NDI) | At baseline and after 6 weeks | The NDI is a self-assessment instrument of the specific functional status of sub jects with neck pain with 10 elements that include pain, personal care, weight gain, reading, headache, concentration, work, driving, sleeping, and leisure. Each section is rated on a scale of 0 to 5, where 0 means "painless" and 5 means "the worst pain imaginable." The points obtained are added to a total score. The questionnaire was interpreted as a per centage. The disability categories for NDI are 0-8%, without disability; 10-28%, mild; 30-48%, moderate; 50-64%, serious; and 70-100%, complete. |
| Primary | Physical and mental health SHORT FORM 12-ITEM SURVEY (SF-12) | At baseline and after 6 weeks | This study used short-form 12-item survey (SF-12) which was derived from short-form 36-item survey (SF-36). It assesses overall physical and mental health status and generates two summary scores: Physical Component Summary (PCS) and Mental Component Summary (MCS). The SF-12 has demonstrated good reliability and validity in both general and specific patient populations. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912099
GET https://conductscience.org/api/trials/v1/NCT07912099/registered